期刊文献+

噻托溴铵中有机溶剂残留量的GC测定 被引量:1

Determination of Residual Organic Solvents in Tiotropium Bromide by GC
下载PDF
导出
摘要 建立了气相色谱法测定噻托溴铵原料药中甲醇、二氯甲烷、乙酸乙酯、甲苯和DMF5种有机溶剂的残留量。采用DB-624毛细管柱,FID检测器,以DMSO为溶剂。结果显示各有机溶剂的平均加样回收率为92.3%~96.8%,RSD为2.4%~5.3%。 A GC method with head space sampling was established for the determination of residual organic solvents -- methanol, dichloromethane, ethyl acetate, toluene and DMF in tiotropium bromide. A DB-624 capillary column was used, with FID as detector and DMSO as the solvent. The average recoveries were 92.3 % - 96.8 %, with RSDs of 2.4% - 5.3%.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2009年第3期207-208,共2页 Chinese Journal of Pharmaceuticals
关键词 噻托溴铵 有机溶剂残留 气相色谱 测定 tiotropium bromide residual organic solvents GC determination
  • 相关文献

参考文献1

二级参考文献17

  • 1Dahl R, Greefhorst A, Nowak D, et al. Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2001,164(5) :778 - 784. 被引量:1
  • 2Rossi A, Kristufek P, Levine B E, et al. Comparison of the efficacy, tolerability, and safety of formoterol dry powder and oral, slow-release theophylline in the treatment of COPD[J].Chest, 2002,121(4) : 1058 - 1069. 被引量:1
  • 3Van Noord J, De Munck D, Bantje T, et al. Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium [ J ]. Eur Respir J, 2000,15(5) :878 - 885. 被引量:1
  • 4Sichletidis L, Kottalds J, Marcou S, et al. Bronchodilatory responses to formoterol,ipratropium, and their combination in patients with stable COPD[J]. Int J Clin Pract, 1999,53(3):185- 188. 被引量:1
  • 5ZuWallack R L, Mahler D A, Reilly D, et al. Salmeterol plus theophylline combination therapy in the treatment of COPD[J].Chest, 2001,119(6) : 1661 - 1670. 被引量:1
  • 6D' Urzo A D, De Salvo M C, Bamirez-Rivera A, et al. In patients with COPD, treatment with a combination of formoterol and ipratropium is more effective than a combination of salbutamol and ipratropium: a 3-week, randomized, doulde-blind, within-patient, multicenter study[J]. Chest, 2001,119(5) : 1347 - 1356. 被引量:1
  • 7Celik G, Kayacan O, Bedex S, et al. Formoterol and salmeterol in partially reversible chronic obstructive pulmonary disease: a crossover, placebo-controlled compaison of onsetand duration of action[J]. Respiration, 1999,66(5):434-439. 被引量:1
  • 8Cazzola M, D'Amato M, Califano C, et al. Formoterol as dry powder oral inbalation compared with salbutamol metered-dose inhaler in acute exacerbations of chronic obstructive pulmonary disease [J].Clin Ther, 2002,24(4):595-604. 被引量:1
  • 9Noord J A V, Bantje T A, Eland M E, et al. A randomized controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease [ J l.Thorax, 2000,55(4) :289-294. 被引量:1
  • 10Vincken W, Noord J A V,Greefhorst A P, et al. Improved health outcomes in patients with COPD during 1 yr' s treatment with tiotropitum[J]. Eur Respir J, 2002,19(2) :209 - 216. 被引量:1

共引文献12

同被引文献2

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部